| First Author | Ewanchuk BW | Year | 2021 |
| Journal | Sci Adv | Volume | 7 |
| Issue | 17 | PubMed ID | 33893096 |
| Mgi Jnum | J:336459 | Mgi Id | MGI:6810016 |
| Doi | 10.1126/sciadv.abd3684 | Citation | Ewanchuk BW, et al. (2021) A non-immunological role for gamma-interferon-inducible lysosomal thiol reductase (GILT) in osteoclastic bone resorption. Sci Adv 7(17) |
| abstractText | The extracellular bone resorbing lacuna of the osteoclast shares many characteristics with the degradative lysosome of antigen-presenting cells. gamma-Interferon-inducible lysosomal thiol reductase (GILT) enhances antigen processing within lysosomes through direct reduction of antigen disulfides and maintenance of cysteine protease activity. In this study, we found the osteoclastogenic cytokine RANKL drove expression of GILT in osteoclast precursors in a STAT1-dependent manner, resulting in high levels of GILT in mature osteoclasts, which could be further augmented by gamma-interferon. GILT colocalized with the collagen-degrading cysteine protease, cathepsin K, suggesting a role for GILT inside the osteoclastic resorption lacuna. GILT-deficient osteoclasts had reduced bone-resorbing capacity, resulting in impaired bone turnover and an osteopetrotic phenotype in GILT-deficient mice. We demonstrated that GILT could directly reduce the noncollagenous bone matrix protein SPARC, and additionally, enhance collagen degradation by cathepsin K. Together, this work describes a previously unidentified, non-immunological role for GILT in osteoclast-mediated bone resorption. |
